Event: EMWA Spring Conference 2026
Date: May 5-8,2026
Location: Barceló Sants Hotel, Barcelona
The European Medical Writers Association was founded in 1989 by a small group of professional biomedical communicators with academic, industrial and journalistic affiliations. EMWA has grown since then and now has over 1,000 members from 39 different countries (including 12 countries outside Europe) and includes academics and professionals working in-house or freelance for pharmaceutical and medical communications companies, research institutes, and in the field of scientific journalism. AlphaLife Sciences is excited to participate and share our insights at the event. We look forward to engaging with you in person!
Booth Number: 1
Presentation from AlphaLife Sciences (two in total):
The first presentation & panel
Date: May 7
Time: 11:00–12:30 CET
Session Title: Inside the Black Box: Building Trustworthy AI Tools for Medical Writing
Host: Dr Namrata Singh, Founder and CEO, Turacoz
Our Speaker:
-Mike Liang, Head of AI Product & Strategy, AlphaLife Sciences
Title: Designing Trustworthy AI for Regulatory Medical Writing
This session offers a practice‑oriented look at AI‑powered tool development and the quality assurance mechanisms required for high‑stakes regulatory writing. We will cover three key aspects:
1. Foundational Design for AI Tools: Architecting for Compliance: We examine how developers build and validate AI systems specifically for medical writing tasks to ensure they are “fit for purpose.” This phase explores how medical writers act as advisors during the development stage, setting compliance standards and providing the domain expertise required to guide responsible AI evolution.
2. Co‑piloted Workflow Orchestration: Ensuring Narrative Integrity: We look at AI‑orchestrated authoring across eCTD documents. This stage highlights human‑in‑the‑loop authoring, end‑to‑end review, and automated quality control. We show how “change intelligence” maintains narrative integrity and structural consistency during complex data updates.
3. Quality Verification: Benchmarking Regulatory Readiness: We discuss how to measure regulatory readiness through professional benchmark design and task‑specific performance assessment. We evaluate five pillars of clinical trust: accuracy, completeness, consistency, factuality, and structural traceability.
The session concludes with practical advice on your evolving role as a “scientist in the loop” and on how to upgrade your skills to thrive in an AI‑augmented regulatory landscape.
The second presentation
Date: May 8
Time: 12:35-13.35 CET
Session: Lunchtime Session
Speaker:
-Mike Liang, Head of AI Product & Strategy, AlphaLife Sciences
-Lucia Damado, Product Specialist, AlphaLife Sciences
Title: Faster AI-Augmented Draft-to-Submission for Clinical Documents: AI Tool Demos
Discover how AI can help you move faster from draft to submission for critical clinical and regulatory documents. In this live, demo-driven webinar, you’ll see practical AI workflows across protocols, CSRs, CTD clinical overviews and summaries, and DSUR/PBRER reports. You’ll learn how AI can cut authoring time, support high-quality first drafts, streamline review and quality control, and use change intelligence across a document network to manage updates more efficiently—while keeping writers firmly in control of content and compliance. Attendees will gain practical insights to support faster, more efficient clinical document authoring across the R&D lifecycle.
To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.
